+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Survival of patients with limited small cell lung cancer in whom complete remission was obtained (a non-randomised retrospective study of 124 consecutive patients



Survival of patients with limited small cell lung cancer in whom complete remission was obtained (a non-randomised retrospective study of 124 consecutive patients



Lung Cancer 13(2): 129-135



The aim of this study was to assess whether thoracic radiotherapy (TRT) is necessary for those patients (pts) with limited small cell lung cancer (SCLC) who obtained CR after induction chemotherapy (ChT). The analysis include retrospective material of 124 consecutive pts with limited SCLC. All pts had induction ChT (3-5 courses): 78 with CAVE (cyclophosphamide, doxorubicine, etoposide) and 46--with other regimens without etoposide. After induction ChT 55 pts were irradiated on tumor and mediastinum and in 69 the same ChT was continued for 6-8 courses or till progression. After induction ChT CR was obtained in 31 pts, PR in 67 and NR in 26. TRT significantly increased the number of CR among those pts who did not achieve satisfactory tumor response after induction ChT. The median survival was 24 months for those patients who obtained CR, 12 months for those who obtained PR and 9 months for those who did not respond. In the group of patients who obtain CR, survival was the same for those treated with ChT alone and for those treated with ChT and TRT. We conclude that in the treatment of individual patient with limited SCLC TRT is indicated for those who did not obtain CR after ChT. Whether patients in whom CR after chemotherapy was obtained can further gain by application of TRT is worth further randomised studies.

(PDF emailed within 0-6 h: $19.90)

Accession: 047501187

Download citation: RISBibTeXText

PMID: 8581392

DOI: 10.1016/0169-5002(95)00486-6


Related references

Brain Metastases in Patients with Limited Small Cell Lung Cancer Achieving Complete Remission. Chest Journal 96(6): 1332-1335, 1989

Brain metastases in patients with limited small cell lung cancer achieving complete remission. Correlation with TNM staging. Chest 96(6): 1332-1335, 1989

Prophylactic cranial irradiation in limited disease small-cell lung cancer in complete remission: a retrospective analysis. Respiratory Medicine 95(3): 235-236, 2001

Survival of 371 consecutive non small cell lung cancer patients retrospective analysis according to the treatment. Uicc (Union Internationale Contre Le Cancer, International Union Against Cancer) 14th International Cancer Congress, Budapest, Hungary, Aug 21-27, Abstracts, Lectures, Symposia And Free Communications, Vols 1, 2, 3, Late Abstracts, And Register Xvi+479p (Vol 1); Xvi+298p (Vol 2); Xvi+531p (Vol 3); 15p (Late Abstracts); 40p (Register) S Karger Ag: Basel, Switzerland; New York, N Y , Usa; Akademiai Kiado: Budapest, Hungary Paper 1263, 1986

The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer. Orvosi Hetilap 146(27): 1433-1438, 2005

Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial. Lancet. Oncology 10(5): 467-474, 2009

Impact of Total Thoracic Radiation Dose and Dose Fractionation on Overall Survival in Limited-Disease Small Cell Lung Cancer: A Retrospective Study on 456 Patients. International Journal of Radiation Oncology*biology*physics 81(2): S588-S589, 2011

Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. Journal of Thoracic Oncology 3(6): 652-655, 2008

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: a double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group. European Journal of Cancer 47(10): 1546-1555, 2011

The role of higher thoracic irradiation doses in patients with limited stage of small-cell lung cancer: Retrospective study. Archive of Oncology 18(1-2): 8-13, 2010

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 366(9496): 1527-1537, 2005

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Yearbook of Oncology 2007: 207-210, 2007

Perioperative blood transfusions and survival in patients with non-small cell lung cancer: a retrospective study. Bmc Anesthesiology 13(1): 42, 2013

Survival and prognostic factors in limited stage small cell lung cancer: A retrospective study from northeast Turkey. Journal of Cancer Research and Therapeutics 12(1): 238-243, 2016

Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions. Japanese Journal of Clinical Oncology 48(1): 82-88, 2017